Plasma proteomic signatures predict incident benign prostatic hyperplasia: a prospective cohort study of 20 996 men

Hao Li, Yangchang Zhang, Li Chen, Jiuhong Yuan, Feng Qin, Xianding Wang, Yang Xiong · 2026

Read Plasma proteomic signatures predict incident benign prostatic hyperplasia: a prospective cohort study of 20 996 men by Hao Li, Yangchang Zhang, Li Chen, Jiuhong Yuan, Feng Qin, Xianding Wang, Yang Xiong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13261327.txt.

Description

Hao Li and colleagues present a 2026 prospective cohort study seeking blood protein signatures that predict benign prostatic hyperplasia. This non-cancerous prostate enlargement is common in older men and causes urinary symptoms. No protein markers existed for predicting who will develop it.

The team followed 20,996 BPH-free men from the UK Biobank and measured 2,920 plasma proteins. Over a median follow-up of 13.38 years, 2,405 men developed the condition. Cox regression linked 92 proteins to risk. A machine-learning model prioritized three: TSPAN1 and KLK3 raised risk, while EDA2R was protective. Together they predicted onset with an AUC of 0.71. Enrichment analysis pointed to immune-inflammatory pathways and tissue remodeling. Genetic analysis suggested TSPAN1 and KLK3 are causally involved, marking them as possible targets for risk assessment and therapy.

Catalog record

CREATORHao Li, Yangchang Zhang, Li Chen, Jiuhong Yuan, Feng Qin, Xianding Wang, Yang Xiong
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36528
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13261327

Browse the full library · About the Tower of Babel